Pemetrexed for the treatment of advanced non-small cell lung cancer (NSCLC): Results from a randomized phase III dose finding trial in patients who progressed following platinum-containing chemotherapy

被引：3

作者：

Cullen, Michael H.

Zatloukal, Petr

Sorenson, Sverre

Novello, Silvia

Fischer, Juergen R.

Anil, Abraham Joy

Zereu, Manuela

Peterson, Patrick

Visseren-Grul, Carla

Iscoe, Neill

机构：

[1] Queen Elizabeth Hosp, Canc Ctr, Birmingham B15 2TH, W Midlands, England

[2] Univ Karlova, Prague, Czech Republic

[3] Univ Hosp, Linkoping, Sweden

[4] Univ Turin, Orbassano, Italy

[5] Klin Loewenstein, Loewenstein, Germany

[6] Cross Canc Inst, Alberta, BC, Canada

[7] Santa Casa Porto Alegre, Porto Alegre, RS, Brazil

[8] Lilly & Co, Indianapolis, IN USA

[9] Eli Lilly Netherlands, Utrecht, Netherlands

[10] Eli Lilly Canada, Danforth, ON, Canada

来源：

关键词：

D O I：

10.1097/01.JTO.0000283106.85632.e3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：S316 / S317

页数：2